← Back to Search

Behavioural Intervention

Experimental Arm / EOC Guidelines for Breast Cancer

N/A

Recruiting

Led By Colin Champ, MD, CSCS

Research Sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 20-89 years

Women with a biopsy proven diagnosis of ductal carcinoma in situ or invasive carcinoma of the breast

Timeline

Screening 3 weeks

Treatment Varies

Follow Up the exercise program will last for 8 weeks and continuously monitored by the pi and clinical team.

Awards & highlights

Study Summary

This trial aims to compare two different group exercise programs for women who have had breast cancer to see which one is better at increasing muscle mass.

Who is the study for?

This trial is for women aged 20-89 who have been treated for breast cancer, including ductal carcinoma in situ or invasive carcinoma. They must have completed certain treatments like surgery, radiation, chemotherapy, hormonal therapy but can't be on active chemotherapy.Check my eligibility

What is being tested?

The study compares two exercise regimens to increase muscle mass after breast cancer treatment. One follows the American College of Sports Medicine guidelines and the other varies repetitions per set (6-12-25).See study design

What are the potential side effects?

Since this trial involves exercise programs rather than medication, side effects may include typical exercise-related issues such as muscle soreness or strain.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 20 and 89 years old.

Select...

I have been diagnosed with a type of breast cancer through a biopsy.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ the exercise program will last for 8 weeks and continuously monitored by the pi and clinical team.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~the exercise program will last for 8 weeks and continuously monitored by the pi and clinical team.

This trial's timeline: 3 weeks for screening, Varies for treatment, and the exercise program will last for 8 weeks and continuously monitored by the pi and clinical team. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Determine changes in muscle and fat mass during and after each exercise regimen

Secondary outcome measures

Determine adherence defined as number of sessions attended of total sessions

Determine changes in strength measured via load calculations (repetitions x sets x weight)

Trial Design

2Treatment groups

Experimental Treatment

Group I: Experimental Arm / EOC GuidelinesExperimental Treatment1 Intervention

The experimental group will use a regimen that is often used by strength and conditioning coaches to maximize hypertrophy, and is part of the standard regimens at the Exercise Oncology Center (EOC)

Group II: Control Arm / ACSM GuidelinesExperimental Treatment1 Intervention

The control group will follow resistance training guidelines from the American College of Sports Medicine (ACSM) with the goal of promoting hypertrophy

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)Lead Sponsor

47 Previous Clinical Trials

13,049 Total Patients Enrolled

3 Trials studying Breast Cancer

8,084 Patients Enrolled for Breast Cancer

Colin Champ, MD, CSCSPrincipal InvestigatorRadiation Oncologist

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this clinical trial currently accepting new participants?

"The current status on clinicaltrials.gov shows that patient recruitment is ongoing for this trial. Initial posting of the study was made on January 9, 2024, with the most recent update dated February 9, 2024."

Answered by AI

Are individuals older than 35 years considered suitable candidates for enrollment in this medical research study?

"The enrollment criteria for this study specifies individuals over 20 years of age but under the age of 89."

Answered by AI

What is the current number of individuals being recruited for participation in this clinical study?

"Affirmative, details on clinicaltrials.gov reveal that this investigation is presently in need of volunteers. Originally listed on January 9th, 2024, the study was recently updated on February 9th, 2024. It aims to recruit a total of 30 participants from one designated site."

Answered by AI